For the first time, it is possible to investigate previously perplexing questions regarding how deletion of FABP4 in distant tissues is implicated in the regulation of atherosclerosis formation, cancer progression, hepatic glucose production, and β-cell biology. Here, FABP4 is linked to cancer.